| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.77B | -12.5% |
| Cost of Revenue | $3.14B | -8.1% |
| Gross Profit | $632.8M | -29.3% |
| R&D Expense | $137.2M | +1.0% |
| SG&A Expense | $616.5M | -1.8% |
| Operating Income | -$22.1M | -109.0% |
| Interest Expense | $31.2M | -7.7% |
| Pre-tax Income | -$42.9M | -119.6% |
| Income Tax | $15.1M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $489.6M | +0.2% |
| Inventory | $634.3M | -15.9% |
| Current Assets | $1.35B | -6.0% |
| Total Assets | $2.02B | -0.4% |
| Current Liabilities | $1.00B | -5.3% |
| Long-term Debt | $473.4M | +13.4% |
| Total Liabilities | $1.53B | -0.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $86.1M | -49.6% |
| Capital Expenditures | $62.5M | +30.8% |
| Investing Cash Flow | -$62.7M | -31.7% |
| Financing Cash Flow | -$800K | +99.2% |
| Free Cash Flow | $23.6M | -80.8% |
| -79.8% |
| Net Income | -$60.1M | -142.2% |
| EPS (Basic) | -$3.40 | -141.7% |
| EPS (Diluted) | -$3.40 | -142.3% |
| Stockholders' Equity |
| $472.0M |
| -0.7% |